NEW YORK, May 6 (GenomeWeb News) - Caliper Life Sciences, of Hopkinton, Mass., will acquire technology developed for cell-based screening assays by Amphora, of Research Triangle Park, N.C., the companies said today. Caliper will use the technology to develop a new calcium-flux assay for G-protein-coupled receptor drug targets.
Â
Amphora will transfer to Caliper its proprietary cell culture techniques, as well as hardware and software upgrades that Amphora has integrated into Caliper's microfluidic screening system. In exchange, Caliper will compensate Amphora with cash, products, and royalties based on future sales of cell-based assays, the companies said.